Novo Nordisk expands legal action to protect patients from non-FDA approved weight-loss drugs

Uh we're starting with news that just crossed a few moments ago. Novo Nordis expanding legal action to protect patents from unsafe non-FDA approved semiglutide. And joining us now is CNBC health and pharmaceuticals reporter Angelica Peebles and CNBC's Brandon Gomez.Uh let's start right here. And Brandon, I'm going to kick this off with you. You're on set with me because we did see him and hers.They reported earnings after the bell last night. It was ugly. They clawed back to the flatline and now they're dow ...